John D. Roberts Lecture
Gates Annex B122
Perspectives on Nucleotide Research for Antiviral Drugs and Expanding Access
John Martin,
Ph.D., CEO,
Gilead Sciences, Inc.,
For more information, please contact Victoria Brennan by phone at 6151 or by email at [email protected].
Event Series
John D. Roberts Lecture Series